RG
REGN icon

Retirement Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Retirement Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$19.3K Buy
20
+1
+5% +$951 0.01% 370
2023
Q4 		$16.7K Buy
19
+1
+6% +$823 0.01% 369
2023
Q3 		$14.8K Hold
18
– – 0.01% 358
2023
Q2 		$12.9K Buy
18
+2
+13% +$1.54K 0.01% 378
2023
Q1 		$13K Hold
16
– – 0.01% 362
2022
Q4 		$12K Buy
+16
New +$11.8K 0.01% 340
2022
Q3 		– Sell
-32
Closed -$19K – 733
2022
Q2 		$19K Buy
32
+16
+100% +$10.4K 0.01% 332
2022
Q1 		$11K Buy
16
+11
+220% +$6.96K ﹤0.01% 447
2021
Q4 		$3K Buy
+5
New +$3.07K ﹤0.01% 586

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Retirement Group's REGN Position: Q1 2024 in Review

Retirement Group increased its Regeneron Pharmaceuticals (REGN) stake by 5.3% in Q1 2024, buying an estimated $951 and bringing the position to 20 shares worth $19.3K. The position accounts for 0.01% of the portfolio, ranked #370.

Retirement Group first reported a position in REGN in Q4 2021 and has held it in 9 quarters since. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Retirement Group held 20 shares of Regeneron Pharmaceuticals worth $19.3K as of Q1 2024.
  • Retirement Group bought 1 Regeneron Pharmaceuticals share in Q1 2024, an estimated $951.
  • Regeneron Pharmaceuticals made up 0.01% of Retirement Group's portfolio in Q1 2024, its #370 holding.
  • Retirement Group first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
  • 1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.